ImmunityBio IBRX
NASDAQ IBRX
$9.44 +0.61 (+6.91%)
As of: Sep 30, 2026 · 3:59 PM EDT

ImmunityBio (IBRX) Interest Expenses (2016 - 2026)

Updated

ImmunityBio (IBRX) reported Interest Expenses of $14.05 million for Q2 2026, down 9.2% from $15.47 million a year earlier and down 3.7% from the prior quarter.

Analysis

ImmunityBio (IBRX) Interest Expenses (2016 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, ImmunityBio's Interest Expenses came in at $58.74 million, down 31.8% year-over-year; for FY2025, it came in at $60.89 million, down 46.9% from FY2024.

  • Interest Expenses has a five-year compound annual growth rate of 46.3% (FY2020 to FY2025).
  • By year, Interest Expenses came in at $114.59 million in FY2024 (-11.1%), $128.85 million in FY2023 (+102.9%), $63.52 million in FY2022 (+327.7%) and $14.85 million in FY2021 (+63.6%).
  • The Q2 2026 figure ranks as the lowest quarterly Interest Expenses since Q2 2022.
  • Year over year, Interest Expenses has now declined in each of the last ten quarters, with an average decline of 29.4% over the last eight quarters.
  • The high point for year-over-year Interest Expenses in five years was Q4 2022 (growth of 536.1%); the low point was Q2 2025 (a decline of 48.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $14.59 million (Q1 2026), $14.84 million (Q4 2025) and $15.26 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 281.00 Mn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -435.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 247.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 ImmunityBio 9.30 Bn 8.06 Bn 50.94 Mn 14.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.05 Mn
Mar 31, 2026 14.59 Mn
Dec 31, 2025 14.84 Mn
Sep 30, 2025 15.26 Mn
Jun 30, 2025 15.47 Mn
Mar 31, 2025 15.31 Mn
Dec 31, 2024 26.02 Mn
Sep 30, 2024 29.32 Mn
Jun 30, 2024 29.79 Mn
Mar 31, 2024 29.46 Mn
Dec 31, 2023 31.78 Mn
Sep 30, 2023 35.02 Mn
Jun 30, 2023 32.24 Mn
Mar 31, 2023 29.82 Mn
Dec 31, 2022 28.56 Mn
Sep 30, 2022 16.76 Mn
Jun 30, 2022 9.70 Mn
Mar 31, 2022 8.49 Mn
Dec 31, 2021 4.49 Mn
Sep 30, 2021 3.61 Mn
API Access

ImmunityBio Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=IBRX&period=max&api_key=YOUR_API_KEY